Skip to main content
. 2021 Oct 13;1(1):100005. doi: 10.1016/j.xgen.2021.100005

Table 1.

Availability of summary statistics and number of statistical tests performed in sequencing versus array-based GWASs

Single-variant array, % (n) Single-variant sequencing, % (n) Aggregate sequencing, % (n)
Summary statistics available without restriction 12 (300) 5 (4) 7 (7)

Number of tests (reporting)

Reported 91 (5,817) 74 (61) 81 (84)
Not reported 9 (610) 26 (21) 19 (20)

Number of tests (distribution) overall overall overall

Minimum 12,033 26,011 339
Q1 899,892 144,477 16,788
Median 5,554,549 548,889 18,665
Q3 9,334,585 8,752,596 20,843
Maximum 90,000,000 32,503,121 129,820,320

WES only WES only

Minimum 26,011 735
Q1 81,843 16,751
Median 158,091 18,360
Q3 235,133 20,000
Maximum 1,810,198 88,183

WGS only WGS only

Minimum 658,234 339
Q1 7,666,134 19,903
Median 12,210,410 32,316
Q3 29,880,479 1,082,577
Maximum 32,503,121 129,820,320

Publications that state that they share summary statistics openly (not including those provided with restricted access). Reported/not reported refers to whether the number of statistical tests performed was detailed in the publication. The number of statistical tests performed in sequencing-based studies is based on publications that provide one “number of statistical tests” (n = 51 of 79 for single-variant analysis, n = 56 of 101 for aggregate analysis). Publications that provide a range of statistical test numbers performed are included in the “reported” category but are not included in the distribution. The data for array-based GWAS were obtained from 2014–2019 studies in the GWAS Catalog (December 2, 2020 release) (see STAR Methods).